Search Results - "MORETTI, R. M"

Refine Results
  1. 1

    Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells by Marelli, M. Montagnani, Limonta, P., Maggi, R., Motta, M., Moretti, R.M.

    Published in The Prostate (01-11-2000)
    “…BACKGROUND The pineal hormone melatonin has been shown to exert a direct oncostatic activity on neoplastic cells, particularly from breast cancer. In the…”
    Get full text
    Journal Article
  2. 2

    Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression by Moretti, R M, Monagnani Marelli, M, van Groeninghen, J C, Motta, M, Limonta, P

    Published in Endocrine-related cancer (01-06-2003)
    “…Luteinizing hormone-releasing hormone (LHRH) is the key hormone in the control of reproductive functions. In recent years, it has become evident that LHRH…”
    Get full text
    Journal Article
  3. 3

    Antiproliferative action of melatonin on human prostate cancer LNCaP cells by Moretti, R M, Marelli, M M, Maggi, R, Dondi, D, Motta, M, Limonta, P

    Published in Oncology reports (01-03-2000)
    “…Recent experimental evidence suggests that melatonin, the major pineal hormone, might possess oncostatic properties. The present experiments were performed to…”
    Get more information
    Journal Article
  4. 4

    LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action by Limonta, P, Montagnani Marelli, M, Moretti, R M

    Published in Expert opinion on investigational drugs (01-04-2001)
    “…Two classes of luteinising hormone-releasing hormone (LHRH) analogues have been developed so far to be used for oncological therapies: LHRH agonists and…”
    Get more information
    Journal Article
  5. 5

    Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145 by MORETTI, R. M, MONTAGNANI MARELLI, M, DONDI, D, POLETTI, A, MARTINI, L, MOTTA, M, LIMONTA, P

    “…LH-releasing hormone (LHRH) agonists exert a direct inhibitory action on the growth of both androgen-dependent (LNCaP) and androgen-independent (DU 145) human…”
    Get full text
    Journal Article
  6. 6

    Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells by Marelli, M M, Moretti, R M, Dondi, D, Motta, M, Limonta, P

    Published in Endocrinology (Philadelphia) (01-01-1999)
    “…We have previously shown that LHRH agonists exert a direct and specific inhibitory action on the proliferation of the androgen-independent DU 145 prostate…”
    Get full text
    Journal Article
  7. 7

    Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145 : evidence for an autocrine-inhibitory LHRH loop by DONDI, D, LIMONTA, P, MORETTI, R. M, MARELLI, M. M, GARATTINI, E, MOTTA, M

    Published in Cancer research (Chicago, Ill.) (01-08-1994)
    “…The therapeutic options for the treatment of androgen-independent prostatic cancers are rather limited; this is mainly because our understanding of the local…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? by Montagnani Marelli, M, Moretti, R M, Januszkiewicz-Caulier, J, Motta, M, Limonta, P

    Published in Current cancer drug targets (01-05-2006)
    “…Gonadotropin-Releasing Hormone (GnRH) is the hypothalamic decapeptide which plays a key role in the control of reproductive functions. By binding to specific…”
    Get more information
    Journal Article
  10. 10

    Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth by Motta, M., Dondi, D., Moretti, R.M., Marelli, M.Montagnani, Pimpinelli, F., Maggi, R., Limonta, P.

    “…Previous work carried out in the authors' laboratory has shown that LHRH agonists directly inhibit the proliferation of hormone-responsive and…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway by Limonta, P, Moretti, R M, Marelli, M M, Dondi, D, Parenti, M, Motta, M

    Published in Endocrinology (Philadelphia) (01-11-1999)
    “…Evidence has accumulated indicating that LHRH might behave as an autocrine/paracrine growth inhibitory factor in some peripheral tumors. However, LHRH…”
    Get full text
    Journal Article
  12. 12

    Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP by Limonta, P, Dondi, D, Moretti, R M, Maggi, R, Motta, M

    “…Highly potent LH-releasing hormone (LHRH) agonists have been recently introduced in therapy for the treatment of the carcinoma of the prostate, an…”
    Get more information
    Journal Article
  13. 13

    Growth of the androgen-dependent tumor of the prostate: Role of androgens and of locally expressed growth modulatory factors by Limonta, Patrizia, Dondi, Donatella, Marelli, Marina Montagnani, Moretti, Roberta M., Negri-Cesi, Paola, Motta, Marcella

    “…The crucial role played by androgens in the growth of prostatic carcinoma is now well established. However, the mechanisms of this proliferative action are…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Growth factors in steroid-responsive prostatic tumor cells by Dondi, Donatella, Moretti, Roberta M., Marelli, Marina Montagnani, Motta, Marcella, Limonta, Patrizia

    Published in Steroids (01-04-1996)
    “…Androgens stimulate the growth of prostatic carcinoma, possibly by modulating the activity of locally expressed growth factors. Recently, we have shown that an…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH by Limonta, P, Moretti, R M, Dondi, D, Marelli, M M, Motta, M

    “…Testosterone (T) is the major exogenous stimulus for the growth of prostatic carcinoma. It is believed that the proliferative action of T may be mediated by…”
    Get more information
    Journal Article
  16. 16

    Characterization of a soluble LHRH-degrading activity in the rat ventral prostate by Maggi, R, Dondi, D, Limonta, P, Pimpinelli, F, Montagnani, M, Moretti, R M, Motta, M

    Published in The Prostate (1993)
    “…Recent evidence supports the hypothesis of a direct action of LHRH at the level of the prostate. Since peptidases able to degrade the hormone are present in…”
    Get more information
    Journal Article
  17. 17

    Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP by Limonta, P, Dondi, D, Moretti, R M, Fermo, D, Garattini, E, Motta, M

    “…Recent evidence suggests that LHRH or a LHRH-like peptide might be produced by human prostatic tumor cells. To test this hypothesis, we have studied whether a…”
    Get more information
    Journal Article
  18. 18

    Oncostatic activity of a thiazolidinedione derivative on human androgen‐dependent prostate cancer cells by Moretti, Roberta M., Montagnani Marelli, Marina, Motta, Marcella, Limonta, Patrizia

    Published in International journal of cancer (01-06-2001)
    “…Thiazolidinedione derivatives with potent antiarthritic activity, such as CGP 52608, have been suggested to exert their biological effects through the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    11712 Didactic and Efficient Robotic Hysterectomy Using Hugo RAS Robotic Platform with Only Three Ports by Jorge Romano, J, Cerqueira, JL, Calazans, L, Corinti, M, Moretti, RM, Tamura, MV, Barison, G

    Published in Journal of minimally invasive gynecology (01-11-2024)
    “…Presenting the surgical challenges of hysterectomy on the new robotic platform Hugo Ras. Case report illustrated with video. Patient under general anesthesia,…”
    Get full text
    Journal Article